ArticleLaboratory investigation; a journal of technical methods and pathology2019

Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma.

Toshihiro Nagato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.